RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding RVL Pharmaceuticals plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 41 | 36 | −5 |
| Shares | 25.2M | 24.1M | −1.09M (−4.3%) |
| Value | $28.7M | $13.5M | −$15.2M (−53.0%) |
New holders (1)
Institutions that held RVL Pharmaceuticals plc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Royal Bank of Canada | 937 | $1.00K | 0.00% |
Sold out (6)
Institutions that held RVL Pharmaceuticals plc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 127,853 | $145.8K |
| Bridgeway Capital Management, LLC | 31,500 | $35.9K |
| Atria Wealth Solutions, Inc. | 23,000 | $26.2K |
| Barclays PLC | 13,697 | $15.6K |
| Squarepoint Ops LLC | 11,299 | $12.9K |
| Tower View Investment Management & Research LLC | 4,100 | $5.00K |